triazoles has been researched along with Kidney Diseases in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.66) | 18.7374 |
| 1990's | 8 (15.09) | 18.2507 |
| 2000's | 10 (18.87) | 29.6817 |
| 2010's | 30 (56.60) | 24.3611 |
| 2020's | 2 (3.77) | 2.80 |
| Authors | Studies |
|---|---|
| Arazy, M; Auner, HW; Benjamin, R; Chai, Y; Delimpasi, S; Dimopoulos, MA; Dolai, TK; Doronin, V; Garg, MK; Gavriatopoulou, M; Grosicki, S; Hájek, R; Kauffman, MG; Leleu, X; Levy, Y; Mateos, MV; Moreau, P; Pylypenko, H; Quach, H; Richardson, PG; Shacham, S; Shah, J; Sinha, DK; Venner, CP | 1 |
| Cheng, CY; Dege, N; Faizi, MSH; Haque, A; Hsieh, MF; Imran Hassan, S; Khan, MS | 1 |
| Akbaba, M; Beck, H; Ergüden, JK; Flamme, I; Hartung, IV; Jeske, M; Karig, G; Keldenich, J; Militzer, HC; Oehme, F; Stoll, F; Thede, K; Thuss, U | 1 |
| Dong, Z; Liu, J; Sun, L; Yuan, Y; Zhang, X | 1 |
| Fagard, L; Harrison, P; Namour, F; Tasset, C; Van der Aa, A; Xin, Y | 1 |
| Baumgartner, S; Goldfarb, DS; Jalal, D; Pillinger, M; Saag, KG; Schechter, BM; Terkeltaub, R; Valiyil, R; White, WB | 1 |
| Gupta, KL; Kohli, HS; Ramachandran, R; Sethi, J | 1 |
| Ahmed, L; Babickova, J; Eikrem, Ø; Furriol, J; Gausdal, G; Landolt, L; Leh, S; Lorens, JB; Marti, HP; Osman, T; Scherer, A; Skogstrand, T; Suliman, S | 1 |
| Alimena, G; Breccia, M | 1 |
| Charles, JI; Jeanbourquin, D; Mostofi, K | 1 |
| Alizadeh, S; Bamedi, T; Dorgalaleh, A; Jahantigh, A; Naderi, M; Sadeghi-Bojd, S; Tabibian, S; Valeshabad, AK | 1 |
| Aroor, AR; Garro, M; Habibi, J; Hayden, MR; Johnson, M; Lastra, G; Manrique, C; Meuth, A; Nistala, R; Sowers, JR; Whaley-Connell, A | 1 |
| Chan, GC; Cheuk, DK; Chiang, AK; Dee, CM; Ha, SY | 1 |
| Erman, A; Feige Gross Nevo, R; Gafter, U; Gafter-Gvili, A; Milo, G; Pazgal, I; Shpilberg, O; Stark, P | 1 |
| Arechavala, A; Carrillo-Muñoz, AJ; Eraso, E; Giusiano, G; Jauregizar, N; Negroni, R; Quindós, G; Tur-Tur, C | 1 |
| Adam, JM; Bendels, S; Bissantz, C; Fingerle, J; Grether, U; Grüner, S; Guba, W; Kimbara, A; Nettekoven, M; Ottaviani, G; Püllmann, B; Rogers-Evans, M; Rothenhäusler, B; Röver, S; Schmitt, S; Schuler, F; Schulz-Gasch, T; Ullmer, C | 1 |
| Cannata-Ortiz, P; Egido, J; Lopez-Larrea, C; Morgado-Pascual, JL; Ortiz, A; Rayego-Mateos, S; Rodrigues-Diez, R; Rodriguez, RM; Ruiz-Ortega, M; Sanz, AB; Suarez-Alvarez, B; Tharaux, PL | 1 |
| Gillen, M; Kerr, B; Lee, CA; Shen, Z; Valdez, S; Zhou, D | 1 |
| Boonprasert, R; Chayakulkeeree, M; Dilokpattanamongkol, P; Panusitthikorn, P; Rotjanapan, P | 1 |
| Poveda, E; Soriano, V | 1 |
| Carter, JE; Culpepper, M; Goel, S; Kahn, AG | 1 |
| Athanassiou-Metaxa, M; Economou, M; Papachristou, F; Printza, N; Teli, A; Tsatra, I; Tzimouli, V | 1 |
| Cadena, JA; Owens, AD; Palacio-Bedoya, F; Patterson, TF; Sutton, DA; Thompson, GR | 1 |
| Corey, M | 1 |
| Inoue, T; Kakita, T; Matsuda, H; Mori, T; Nagatoya, K; Teranishi, J; Yamauchi, Y | 1 |
| Bhalodia, Y; Manek, R; Sheth, N; Vaghasiya, J | 1 |
| Jarque, I; Salavert, M | 1 |
| López-Hernandez, FJ; López-Novoa, JM; Macías-Nuñez, JF; Morales, AI; Sánchez-González, PD | 1 |
| Alivanis, P; Aperis, G | 1 |
| Lombardi, LR; Marr, KA; Neofytos, D; Nguyen, MH; Ostrander, D; Shields, RK; Thompson, CB; Warren, L | 1 |
| Cochat, P; Dubourg, L; Hadj-Aïssa, A; Laurain, C; Pondarré, C; Ranchin, B; Sigaudo-Roussel, D | 1 |
| Alimena, G; Breccia, M; Colafigli, G; Federico, V; Finsinger, P; Latagliata, R; Loglisci, G; Petrucci, L; Salaroli, A; Santopietro, M; Serrao, A | 1 |
| Bhandari, S; Daar, S | 1 |
| Logan, BR; Zhang, MJ | 1 |
| Aydinok, Y; Chan, LL; El-Beshlawy, A; Elalfy, MS; Habr, D; Lee, SH; Martin, N; Porter, JB; Sutcharitchan, P; Taher, AT | 1 |
| Ullmann, AJ | 1 |
| Ermert, L; Lohmeyer, J; Lommel, D; Ludwig, M; Schneider, H; Sziegoleit, A; Weidner, W | 1 |
| Huber, AC; Matuszewski, BK; Merschman, SA; Musson, DG; Pearce, GE; Perry, KJ; Rose, MJ; Rush, DJ; Schaefer, BH; Varsolona, RJ; Woolf, EJ | 1 |
| Einstein, HE; Johnson, RH | 1 |
| Vichinsky, E | 1 |
| Meessen, NE; Oosten, AW; Sprenger, HG; van Assen, S; van Leeuwen, JT | 1 |
| Cloyd, J; Critchley, D; Fuseau, E; Perucca, E | 1 |
| Ishidoya, S; Klahr, S; Morrissey, J | 1 |
| Mugford, CA; Tarloff, JB | 2 |
| Barbhaiya, RH; Greene, DS; Shukla, UA | 1 |
| Barbhaiya, RH; Brady, ME; Greene, DS; Shukla, UA | 1 |
| Andriole, VT; George, D; Miniter, P | 1 |
| Barbhaiya, RH; Greene, DS | 1 |
| Ryley, JF; Ryley, NG | 1 |
| Dave, J; Hickey, MM; Wilkins, EG | 1 |
| Ackerbauer, H; Meingassner, JG; Mieth, H | 1 |
| Göttinger, E | 1 |
14 review(s) available for triazoles and Kidney Diseases
| Article | Year |
|---|---|
Efficacy and safety of deferasirox in myelodysplastic syndromes.
Topics: Benzoates; Chelation Therapy; Clinical Trials, Phase II as Topic; Deferasirox; Drug Eruptions; Drug Therapy, Combination; Ferritins; Gastrointestinal Diseases; Humans; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Multicenter Studies as Topic; Myelodysplastic Syndromes; NF-kappa B; Oxidative Stress; Prospective Studies; Retrospective Studies; Survival Analysis; Transfusion Reaction; Triazoles | 2013 |
Cervical spondylitis due to Phaeoacremonium venezuelense in an immunocompetent patient. A first case report.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Cervical Vertebrae; Epidural Abscess; Humans; Immunocompetence; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Species Specificity; Spondylitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
[Clinical usefulness of triazole derivatives in the management of fungal infections].
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Fungal; Fungal Proteins; Humans; Kidney Diseases; Mycoses; Squalene Monooxygenase; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2015 |
[Pharmacokinetics, interactions and mechanism of action of maraviroc].
Topics: Adolescent; Adult; Aged; Biological Availability; Biotransformation; CCR5 Receptor Antagonists; Chemokines, CC; Clinical Trials as Topic; Cyclohexanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Design; Drug Interactions; env Gene Products, Human Immunodeficiency Virus; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Kidney Diseases; Liver Diseases; Maraviroc; Membrane Fusion; Receptors, CCR5; Triazoles; Virus Attachment; Virus Internalization; Virus Replication | 2008 |
Modern antifungal therapy for neutropenic fever.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].
Topics: Adult; Ambulatory Care; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Male; Meta-Analysis as Topic; Micafungin; Mycoses; Postoperative Complications; Practice Guidelines as Topic; Triazoles | 2011 |
Posaconazole: a new antifungal weapon.
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Fungal; Humans; Immunocompromised Host; Kidney Diseases; Mycoses; Opportunistic Infections; Triazoles | 2011 |
Pharmacological aspects of the new triazole voriconazole.
Topics: Antifungal Agents; Contraindications; Drug Interactions; Humans; Kidney Diseases; Liver Diseases; Pyrimidines; Triazoles; Voriconazole | 2002 |
Systemic aspergillosis with predominant genitourinary manifestations in an immunocompetent man: what we can learn from a disastrous follow-up.
Topics: Abscess; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Diseases; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Peptides, Cyclic; Prostatic Diseases; Pyrimidines; Retroperitoneal Space; Triazoles; Voriconazole | 2005 |
Amphotericin B and coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; Deoxycholic Acid; Drug Combinations; Female; Humans; Kidney Diseases; Lipids; Meningitis; Pregnancy; Treatment Outcome; Triazoles | 2007 |
Clinical application of deferasirox: practical patient management.
Topics: Administration, Oral; Adult; Benzoates; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Contraindications; Creatinine; Deferasirox; Disease Management; Drug Eruptions; Gastrointestinal Diseases; Hematologic Diseases; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Transfusion Reaction; Triazoles | 2008 |
Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Aspergillus fumigatus; HIV Infections; Humans; Kidney Diseases; Male; Pyrimidines; Radiography; Tomography Scanners, X-Ray Computed; Triazoles; Voriconazole | 2008 |
Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Enalapril; Extracellular Matrix Proteins; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Macrophages; Monocytes; Rats; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Triazoles; Ureteral Obstruction | 1995 |
Clinical pharmacokinetics of nefazodone.
Topics: Adult; Age Factors; Aged; Analgesics; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Female; Humans; Kidney Diseases; Liver Diseases; Male; Piperazines; Sex Factors; Triazoles | 1997 |
3 trial(s) available for triazoles and Kidney Diseases
| Article | Year |
|---|---|
Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Dexamethasone; Disease-Free Survival; Female; Humans; Hydrazines; Kidney Diseases; Male; Middle Aged; Multiple Myeloma; Survival Rate; Triazoles | 2022 |
A prospective study of tubular dysfunction in pediatric patients with Beta thalassemia major receiving deferasirox.
Topics: Adolescent; Benzoates; beta-Thalassemia; Blood Transfusion; Child; Child, Preschool; Creatinine; Deferasirox; Female; Glomerular Filtration Rate; Humans; Iron Chelating Agents; Iron Overload; Kidney Diseases; Male; Metals; Prospective Studies; Triazoles | 2013 |
Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers.
Topics: Administration, Oral; Adult; Aged; Area Under Curve; Biological Availability; Biomarkers; Creatinine; Female; Glomerular Filtration Rate; Gout Suppressants; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Renal Elimination; Severity of Illness Index; Thioglycolates; Triazoles; Uric Acid | 2016 |
36 other study(ies) available for triazoles and Kidney Diseases
| Article | Year |
|---|---|
1,4-Disubstituted 1
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Survival; Cellobiose; Crystallography, X-Ray; Cyclooxygenase 2; Free Radicals; Group IV Phospholipases A2; Humans; Inflammation; Kidney Diseases; Lipopolysaccharides; Matrix Metalloproteinase 9; Mesangial Cells; Mitochondria; Molecular Docking Simulation; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Triazoles | 2020 |
Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia.
Topics: Anemia; Animals; Binding Sites; Cell Line, Tumor; Drug Discovery; Humans; Hypoxia-Inducible Factor-Proline Dioxygenases; Kidney Diseases; Mice; Molecular Structure; Protein Binding; Protein Conformation; Pyrazoles; Structure-Activity Relationship; Triazoles | 2018 |
Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity.
Topics: A549 Cells; Animals; Antioxidants; Apoptosis; Azepines; Checkpoint Kinase 2; Cisplatin; Cytoprotection; Disease Models, Animal; DNA Damage; Enzyme Activation; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Nitrosative Stress; Oxidative Stress; Phosphorylation; Signal Transduction; Triazoles; Tumor Suppressor Protein p53; Weight Loss | 2018 |
Influence of age and renal impairment on the steady state pharmacokinetics of filgotinib, a selective JAK1 inhibitor.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; Female; Glomerular Filtration Rate; Humans; Janus Kinase 1; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Pyridines; Triazoles | 2018 |
Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gout; Gout Suppressants; Humans; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic; Thioglycolates; Treatment Outcome; Triazoles; Uric Acid; Xanthine Oxidase; Young Adult | 2019 |
Isolated renal mucormycosis in a patient with Idiopathic CD4 lymphocytopenia.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Diagnosis, Differential; Female; Humans; Kidney; Kidney Diseases; Mucormycosis; T-Lymphocytopenia, Idiopathic CD4-Positive; Triazoles | 2018 |
AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction.
Topics: Animals; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Disease Models, Animal; Epithelial-Mesenchymal Transition; Extracellular Matrix Proteins; Fibrosis; Gene Expression Regulation; Inflammation Mediators; Kidney; Kidney Diseases; Macrophages; Male; Mice, Inbred C57BL; Myofibroblasts; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Signal Transduction; Triazoles; Ureteral Obstruction | 2019 |
Prevention of obesity-induced renal injury in male mice by DPP4 inhibition.
Topics: Animals; Body Weight; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Insulin Resistance; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Obesity; Triazoles | 2014 |
Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia.
Topics: Adolescent; Alkalosis; Benzoates; beta 2-Microglobulin; beta-Thalassemia; Chelation Therapy; Child; Child, Preschool; Deferasirox; Deferiprone; Deferoxamine; Fanconi Syndrome; Female; Humans; Iron Chelating Agents; Kidney Diseases; Kidney Tubules; Male; Pyridones; Retrospective Studies; Transfusion Reaction; Triazoles; Water-Electrolyte Imbalance; Young Adult | 2014 |
GFR in Patients with β-Thalassemia Major.
Topics: Adult; Benzoates; beta-Thalassemia; Biomarkers; Creatinine; Deferasirox; Female; Glomerular Filtration Rate; Humans; Inulin; Iron Chelating Agents; Israel; Kidney; Kidney Diseases; Male; Models, Biological; Outpatient Clinics, Hospital; Predictive Value of Tests; Reproducibility of Results; Transfusion Reaction; Triazoles; Young Adult | 2015 |
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Humans; Inflammation; Kidney Diseases; Models, Molecular; Molecular Structure; Pyrimidines; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Triazoles | 2016 |
Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.
Topics: Animals; Azepines; Chromosomal Proteins, Non-Histone; Disease Models, Animal; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Nuclear Proteins; Transcription Factors; Triazoles | 2017 |
A case report of intravenous posaconazole in hepatic and renal impairment patient with invasive Aspergillus terreus infection: safety and role of therapeutic drug monitoring.
Topics: Administration, Intravenous; Adult; Antifungal Agents; Aspergillus; Drug Monitoring; Fatal Outcome; Humans; Invasive Pulmonary Aspergillosis; Kidney Diseases; Liver Diseases; Male; Triazoles | 2017 |
Primary renal zygomycotic infarction mimicking renal neoplasia in an immunocompetent patient.
Topics: Adrenalectomy; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Humans; Immunocompetence; Kidney Diseases; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Zygomycosis | 2009 |
Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox.
Topics: Adolescent; Adult; Benzoates; beta 2-Microglobulin; beta-Thalassemia; Biomarkers; Chelation Therapy; Child; Child, Preschool; Cystatin C; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Early Diagnosis; Female; Humans; Hypercalciuria; Iron Chelating Agents; Kidney Diseases; Kidney Function Tests; Male; Proteinuria; Pyridones; Triazoles; Young Adult | 2010 |
A noninvasive renal fungus ball caused by Rhizopus--a previously unreported manifestation of zygomycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Humans; Kidney Diseases; Kidney Pelvis; Male; Mucormycosis; Renal Insufficiency; Rhizopus; Triazoles; Ureter | 2010 |
Voriconazole-associated salt-losing nephropathy.
Topics: Aged; Antifungal Agents; Biomarkers; Chemical and Drug Induced Liver Injury; Fluid Therapy; Humans; Hyponatremia; Kidney Diseases; Liver; Male; Neurophysins; Protein Precursors; Pyrimidines; Renin; Sodium; Sodium Chloride; Time Factors; Treatment Outcome; Triazoles; Vasopressins; Voriconazole; Water-Electrolyte Balance | 2010 |
Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes.
Topics: Animals; Apoptosis; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; DNA Fragmentation; Female; Glutathione; Glutathione Peroxidase; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Oxidative Stress; Peroxidase; Pyrazines; Rats; Rats, Wistar; Reperfusion Injury; Sitagliptin Phosphate; Superoxide Dismutase; Triazoles; Xanthine Oxidase | 2011 |
Effects of deferasirox on renal function and renal epithelial cell death.
Topics: Acetylglucosaminidase; Animals; Apoptosis; Benzoates; Cell Adhesion Molecules; Cell Line; Chick Embryo; Clusterin; Cystatin C; Deferasirox; Epithelial Cells; Glomerular Filtration Rate; Histocytochemistry; Iron Chelating Agents; Kidney; Kidney Diseases; Lipocalins; Male; Rats; Rats, Wistar; Triazoles | 2011 |
Administration of voriconazole in patients with renal dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Creatinine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2012 |
Deferasirox-induced renal impairment in children: an increasing concern for pediatricians.
Topics: Administration, Oral; Adolescent; Age Factors; Benzoates; Child; Deferasirox; Female; Glomerular Filtration Rate; Humans; Inulin; Iron Chelating Agents; Iron Overload; Kidney Diseases; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Prospective Studies; Time Factors; Transfusion Reaction; Triazoles | 2012 |
Deferasirox treatment for myelodysplastic syndromes: "real-life" efficacy and safety in a single-institution patient population.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Azacitidine; Benzoates; Chelating Agents; Deferasirox; Drug Eruptions; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematinics; Humans; Iron Overload; Kidney Diseases; Lenalidomide; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Thalidomide; Treatment Outcome; Triazoles | 2012 |
Deferasirox and renal dysfunction in children.
Topics: Benzoates; Deferasirox; Female; Humans; Iron Chelating Agents; Kidney Diseases; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Triazoles | 2012 |
The use of group sequential designs with common competing risks tests.
Topics: Blood Platelets; Clinical Trials as Topic; Computer Simulation; Cord Blood Stem Cell Transplantation; Fluconazole; Humans; Kidney Diseases; Pyrimidines; Research Design; Risk; Sample Size; Statistics as Topic; Triazoles; Voriconazole | 2013 |
Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy.
Topics: Adolescent; Adult; Benzoates; Chelation Therapy; Child; Child, Preschool; Cholelithiasis; Clinical Trials, Phase III as Topic; Creatinine; Deferasirox; Edema; Ethnicity; Female; Ferritins; Gastrointestinal Diseases; Hematologic Diseases; Hepatitis, Viral, Human; Humans; Infant; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Liver; Magnetic Resonance Imaging; Male; Multicenter Studies as Topic; Prospective Studies; Thalassemia; Transfusion Reaction; Triazoles; Young Adult | 2013 |
Characterization of the solubility of a poorly soluble hydroxylated metabolite in human urine and its implications for potential renal toxicity.
Topics: Animals; Chromatography, High Pressure Liquid; Female; Humans; Hydroxylation; Kidney Diseases; Male; Mass Spectrometry; Phthalazines; Psychotropic Drugs; Rats; Solubility; Temperature; Triazoles | 2005 |
Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Topics: Administration, Oral; Adolescent; Age Factors; Anticonvulsants; Body Mass Index; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Female; Food; Half-Life; Humans; Intrinsic Factor; Kidney Diseases; Liver Diseases; Male; Metabolic Clearance Rate; Renal Dialysis; Sex Factors; Syndrome; Triazoles | 2008 |
Contribution of oxidation and deacetylation to the bioactivation of acetaminophen in vitro in liver and kidney from male and female Sprague-Dawley rats.
Topics: Acetaminophen; Animals; Biotransformation; Carbon Radioisotopes; Female; Kidney; Kidney Diseases; Liver; Male; Nitrophenols; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Sex Factors; Triazoles | 1995 |
Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment.
Topics: Administration, Oral; Adult; Age Factors; Aged; Antidepressive Agents; Female; Humans; Kidney Diseases; Liver Cirrhosis; Male; Middle Aged; Piperazines; Serotonin Receptor Agonists; Triazoles | 1995 |
Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function.
Topics: Antidepressive Agents; Female; Humans; Kidney Diseases; Male; Middle Aged; Piperazines; Serotonin Receptor Agonists; Triazoles | 1995 |
Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Azoles; Female; Kidney Diseases; Liver Diseases; Lung Diseases, Fungal; Pyrimidines; Rabbits; Triazoles; Voriconazole | 1996 |
The contribution of oxidation and deacetylation to acetaminophen nephrotoxicity in female Sprague-Dawley rats.
Topics: Acetaminophen; Acetylation; Analgesics, Non-Narcotic; Animals; Blood Urea Nitrogen; Female; Glutathione; Kidney; Kidney Diseases; Liver; Male; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Sex Characteristics; Triazoles; Tritolyl Phosphates | 1997 |
Candida albicans--do mycelia matter?
Topics: Amphotericin B; Animals; Candida albicans; Candidiasis; Culture Media; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Mice; Triazoles | 1990 |
Fluconazole in renal candidosis.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Kidney Diseases; Male; Middle Aged; Triazoles | 1989 |
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles | 1985 |
[Toxicology of chemical sweetening agents].
Topics: Abnormalities, Drug-Induced; Animals; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Chromosome Aberrations; Chromosome Disorders; Cyclamates; Cyclohexylamines; Depression, Chemical; Esters; Guinea Pigs; Humans; Kidney Diseases; Mice; Pancreatic Diseases; Peptides; Phenylalanine; Photosensitivity Disorders; Rats; Saccharin; Sweetening Agents; Tolbutamide; Triazoles; Urinary Bladder Neoplasms | 1971 |